Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
Rituximab (marketed as Rituxan), Information
Extensive bilateral lower extremity deep venous thrombosis in a patient on dimethyl fumarate.
U.S. Patent Office Declares an Interference Between Forward Pharma and Biogen Regarding the Treatment of Multiple Sclerosis With 480 mg Daily Dose of DMF, the Active Ingredient in Tecfidera(R)
The Role of Endogenous IFN-β in the Regulation of Th17 Responses in Patients with Relapsing-Remitting Multiple Sclerosis.
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis.
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.
Prediction of oxygen uptake during walking in ambulatory persons with multiple sclerosis.
Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b.
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Correction: Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Drugs@FDA (Enter "glatiramer acetate" in search box.)
American Neurological Association Annual Meeting
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Pathogenic implications of iron accumulation in multiple sclerosis.
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.
Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a.
Rapid exacerbation of neuromyelitis optica after rituximab treatment.
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity.
Risks of immune system treatments.
Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories.
Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
Benzothiazole and stilbene derivatives as promising PET myelin radiotracers for multiple sclerosis.
G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.

Pages